Drug discovery and computational strategies in the multitarget drugs era
The pharmaceutical industry is increasingly joining chemoinformatics in the search for the development of new drugs to be used in the treatment of diseases. These computational studies have the advantage of being less expensive and optimize the study time, and thus the interest in this area is incre...
Сохранить в:
Главные авторы: | , , , , , |
---|---|
Формат: | |
Опубликовано: |
Universidade de São Paulo,
2018-11-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_e5ed8b0ffbe246788c7302e7ba46c9c5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Jéssika de Oliveira Viana |e author |
700 | 1 | 0 | |a Mayara Barbalho Félix |e author |
700 | 1 | 0 | |a Mayara dos Santos Maia |e author |
700 | 1 | 0 | |a Vanessa de Lima Serafim |e author |
700 | 1 | 0 | |a Luciana Scotti |e author |
700 | 1 | 0 | |a Marcus Tullius Scotti |e author |
245 | 0 | 0 | |a Drug discovery and computational strategies in the multitarget drugs era |
260 | |b Universidade de São Paulo, |c 2018-11-01T00:00:00Z. | ||
500 | |a 2175-9790 | ||
500 | |a 10.1590/s2175-97902018000001010 | ||
520 | |a The pharmaceutical industry is increasingly joining chemoinformatics in the search for the development of new drugs to be used in the treatment of diseases. These computational studies have the advantage of being less expensive and optimize the study time, and thus the interest in this area is increasing. Among the techniques used is the development of multitarget directed ligands (MTDLs), which has become an ascending technique, mainly due to the improvement in the quality of treatment involving several drugs. Multitarget therapy is more effective than traditional drug therapy that emphasizes maximum selectivity for a single target. In this review a multitarget drug survey was carried out as a promising strategy in several important diseases: neglected diseases, neurodegenerative diseases, AIDS, and cancer. In addition, we discuss Computer-Aided Drug Design (CADD) techniques as a tool in the projection of multitarget compounds against these diseases. | ||
546 | |a EN | ||
690 | |a Drug design | ||
690 | |a Multitarget compounds | ||
690 | |a In silico | ||
690 | |a Diseases | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss spe (2018) | |
787 | 0 | |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000700409&lng=en&tlng=en | |
787 | 0 | |n https://doaj.org/toc/2175-9790 | |
856 | 4 | 1 | |u https://doaj.org/article/e5ed8b0ffbe246788c7302e7ba46c9c5 |z Connect to this object online. |